Haemonetics Corp.

Haemonetics Corp.

HAE

Market Cap$3.69B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Haemonetics Corp.Haemonetics Corp.22.6-18%2.81.3
$169.08

Current Fair Value

122.6% upside

Undervalued by 122.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.69 Billion
Enterprise Value$4.61 Billion
Dividend Yield$0 (0%)
Earnings per Share$3.31
Beta0.37
Outstanding Shares49,193,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio22.55
PEG12.21
Price to Sales2.81
Price to Book Ratio4.0
Enterprise Value to Revenue3.39
Enterprise Value to EBIT20.36
Enterprise Value to Net Income27
Total Debt to Enterprise0.27
Debt to Equity1.29

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Haemonetics Corp.

CEO: Christopher Simon